“José Gabay” Course: Interview to Leandro Lasave

After the successful 8th edition of the ProEducar “José Gabay” Course (which took place on August 1st, 2017, at the Hilton Buenos Aires Hotel), it is time to assess its outcomes. In this case, Dr. Leandro Lasave, the Director of the José Gabay Course, analyzed the results of the aforementioned course and SOLACI’s educational work in the promotion of interventional cardiology in Latin America.

Dr. Leandro Lasave

What is your final conclusion regarding the eighth edition of the ProEducar “José Gabay” Course?

The course was successful for the eighth consecutive time; there were over 140 attendees who stayed for the whole 12 hours of the course. That is significant, because it means that all topics caught the attention of the audience. That is my analysis as regards attendance.

 

Another fundamental aspect was the excellence that characterized all presentations. Lecturers exhibited an extremely high level. Among them we can count Dr. Ricardo Petraco, a world-renowned Brazilian physician who has resided in London for the past 11 years. The same can be said about world-class physician Dr. Juan Granada, from the United States, as well as many of the local and Latin American experts present. That is my analysis as regards scientific presentations.

 

The course consisted in 12 intensive hours of deep scientific activity. In that sense, all talks caught the attention of the audience and spurred debate and interaction among fellows, which is important because that is what we aim for.

 

How important is the fact that SOLACI promotes educational spaces such as this one for fellows in Latin America?

Since its foundation, SOLACI has been aimed at the continuous training of Latin American physicians and the homogenization of theory and training. In consequence, the promotion and encouragement provided by SOLACI is fundamental. In other words, that is what SOLACI is: support to continuous training. Our approach to this task is itinerant, i.e., we go country by country, using the course to call upon interventional trainees but also professionals who want to stay updated. As I have already mentioned, this 12-hour course deals with all the important topics, thus becoming an interesting source of updated information for fully trained physicians.

 

This promotion is part of SOLACI’s objectives. It is in its foundations.

 

As regards the future, what are your expectations for ProEducar?

ProEducar is a continuing training program. In consequence, we are constantly looking for ways to evolve. This course actually derived from such evolution, eight years ago. In that sense, it is anything but static: topics and hours change according to current needs.

 

On the other hand, ProEducar’s mission is to keep evolving in its quest for continuous education by means of tools other than the course. As an example, there is a bulletin, which is also in constant transformation. We are also assessing the possibility of creating an educational course that remains over time, a long-lasting course.

 

What would you say to young interventional cardiologists who have just graduated and are starting with their professional career?

In my opinion, many interventional trainees leave their training to everyday practice in the cath lab. It is essential for them not to neglect theory, which is a fundamental means of training. That is why these activities and courses are so significant. Practice is important, but it is not everything. In my opinion, theoretical training of new interventional trainees is a pending issue. In consequence, these opportunities are ideal and trainees should make the most of them.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Watch again – New Guidelines for the Management of Heart Valve Disease: Implications for Interventional Cardiology

You can now watch our webinar on “New Guidelines for the Management of Heart Valve Disease: Implications for Interventional Cardiology”, held via Zoom on...

ESC 2025: Results of the NEO-MINDSET study — exclusive presentation and analysis with Dr. Pedro Lemos

Following the presentation of the NEO-MINDSET study in the Late Breaking Clinical Trials sessions at the European Society of Cardiology Congress (ESC 2025), Dr....

SOLACI Webinar – New Guidelines for the Management of Valvular Heart Disease: Implications for Interventional Cardiology

A new SOLACI virtual scientific event is coming up as part of the scientific coverage of the ESC 2025 Congress. This session will focus on...

SOLACI-SOCIME 2025: Day 3 Highlights

The third and final day of the SOLACI-SOCIME 2025 Congress concluded with a high-impact scientific agenda, featuring joint sessions with prestigious international institutions and...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Should Early Aortic Valve Replacement Be Indicated in Asymptomatic Severe Aortic Stenosis?

A Meta-Analysis of Randomized Clinical Trials. The management of aortic stenosis in asymptomatic patients remains a matter of debate. Traditionally, a conservative strategy has been...

Angioplasty vs Carotid Endarterectomy: Systematic Review and Meta-Analysis of Randomized Clinical Trials

Courtesy of Dr. Juan Manuel Pérez. Carotid stenosis is a major risk factor for stroke. Its treatment includes carotid endarterectomy (CEA), which is considered the...

Provisional Angioplasty in Left Main: What MSA Values Should We Target?

Percutaneous coronary intervention (PCI) of the unprotected left main coronary artery (LMCA) represents one of the most challenging scenarios. Clinical practice guidelines recommend the...